CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - 9 months ended Sep. 30, 2022 - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Capital Surplus	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Unvested Restricted Stock
Beginning balance (in shares) at Dec. 31, 2021		0	9,012,857
Beginning balance at Dec. 31, 2021	$ 177,198	$ 0	$ 45,064	$ 80,640	$ 49,858	$ 2,113	$ (477)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	16,479				16,479
Exercise of common stock options (in shares)			14,300
Exercise of common stock options	206		$ 71	135
Issuance of restricted stock (in shares)			24,265
Issuance of restricted stock	0		$ 121	379			(500)
Repurchase of common stock under the stock repurchase program (in shares)			(345,502)
Repurchase of common stock under the stock repurchase program	(7,356)		$ (1,727)	(5,629)
Stock-based compensation	695			310			385
Common stock dividends paid	(2,381)				(2,381)
Other comprehensive loss	(14,516)					(14,516)
Ending balance (in shares) at Sep. 30, 2022		0	8,705,920
Ending balance at Sep. 30, 2022	$ 170,325	$ 0	$ 43,529	$ 75,835	$ 63,956	$ (12,403)	$ (592)